From the blog

Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma (SCITH-MESO)

Published: April 9, 2021

Primary Outcome Measures

  1. For patients with MPM, blood samples are collected and a piece of biopsy will be used for the constitution of a specific bio collection in the CRB (centre de ressources biologiques). [ Time Frame: day 1 (day of chirurgie) ]
    For patients with MPM, blood samples are collected and a piece of biopsy will be used for the constitution of a specific bio collection in the CRB (centre de ressources biologiques).

Inclusion Criteria

  • age >18
  • suspected MPM requiring VATS biopsy after multidisciplinary oncologic board validation
  • patient able to understand study objectives and able to give an informed consent
  • patient affiliated to an healthcare society.

Exclusion Criteria

  • pregnancy
  • mental disease, psychiatric disorder
  • patient under protection regimen
Contact Us
CONTACT INFORMATION
DIAGNOSIS
Have you received a diagnosis? *
reCAPTCHA